Brand-name vs compounded
altRx vs Ro.co: Brand-Name or Compounded? (2026)
Compare altRx and Ro.co on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 8.7 and 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Two platforms, one drug class, and a difference in annual cost most people do not notice until month four. That is the altRx versus Ro.co question.
Choosing between them is really choosing between an approved finished drug and a compounded preparation. Ro.co sits on one side of that line and altRx on the other, and no amount of feature comparison makes the distinction go away.
This comparison works from what each provider publishes: the entry price, what it becomes at month two, the medication actually dispensed, and what is bundled rather than billed. Where a provider quotes only after intake, that is recorded as the answer rather than replaced with a guess.
The short answer
- Lowest ongoing rate
- Ro.co — $39/mo against $89/mo, though only one of the two publishes enough to total a full year.
- FDA-approved medication
- Ro.co — FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables — a finished product the FDA has reviewed, rather than a compounded preparation.
- Tirzepatide access
- altRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Most support included
- altRx — Responsive care team for ongoing clinician-guided support.
altRx and Ro.co, side by side
Nothing in this table is our estimate. Where a provider does not publish something, the cell says so.
| altRx | Ro.co | |
|---|---|---|
| Advertised price | Semaglutide $89/mo, tirzepatide $149/mo | Get started online for $39 |
| Rate after promotions | $89/mo | $39/mo |
| Pricing structure | Flat rate at every dose | Promotional first month, then standard rate |
| Medication | Compounded semaglutide and compounded tirzepatide | FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables |
| Shipping | Free, discreet 2-day delivery | Home delivery |
| Support model | Clinician messaging included | Provider check-ins included |
| Tirzepatide | $149/mo | Not published |
| Price transparency | Published upfront | Partly published |
| Patient reviews | 14,820 | 40,215 |
| eRxDoctor score | 8.7/10 | 7.5/10 |
The real cost: six months and twelve
The advertised rate answers the wrong question. Below, both are carried out to six and twelve months so the comparison holds at the point it matters.
| altRx | Ro.co | |
|---|---|---|
| First month | $89 | $39 |
| Months 2 onward | $89/mo | Not published |
| 6-month total | $534 | Not computable |
| 12-month total | $1,068 | Not computable |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Ro.co: ongoing medication pricing varies by plan and is set after the consultation. Treat any comparison that quotes one as an estimate someone else has made for you.
What is actually in the vial
Ro.co supplies FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables. A brand-name GLP-1 is a finished drug the FDA has reviewed for safety, efficacy and manufacturing quality, and every vial or pen is the same product made to the same specification.
altRx works with compounded semaglutide and compounded tirzepatide. Compounding is what puts $89/mo within reach; it also means no approval application stands behind the specific product you receive.
This is the decision to make deliberately rather than by price. If the regulatory status of what you are injecting weekly matters to you, that settles it toward Ro.co; if cost is the barrier that has kept you from treating at all, altRx exists for a reason.
How altRx works
altRx is the most affordable GLP-1 program, limited offer: semaglutide $89/month and tirzepatide $149/month. 100% online medical visits, no membership, insurance or hidden fees, free and discreet 2-day delivery. In this pairing, its distinguishing feature is the cheapest published tirzepatide rate on this list at $149, with the injection kit included.
The process is 100% online medical visits, then free, discreet 2-day delivery. On money, expect flat rate at every dose — published upfront.
Behind the prescription sits responsive care team for ongoing clinician-guided support. Available medication: compounded semaglutide and compounded tirzepatide.
altRx pros
- Free and discreet 2-day delivery
- No commitment, cancel anytime
- Complete treatment kit: vials, syringes, prep pads, and step-by-step guidance
- Responsive care team for ongoing clinician-guided support
altRx cons
- Compounded medication, not FDA-approved branded product
- Not available in all U.S. states
The cost of choosing this over Ro.co: the rate is a limited offer and the platform does not operate in every state.
Inside the Ro.co program
The pitch is the only mainstream platform here offering the FDA-approved Wegovy pill, so no injections at all. Get Started Online for Just $39
Getting started means online consultation, after which home delivery. Pricing runs on a promotional first month, then standard rate basis, partly published.
On the clinical side, established full-service platform with clinician oversight, prescribing FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables.
Ro.co pros
- Only mainstream platform offering the FDA-approved Wegovy pill, oral GLP-1, no injections
- Get started online for just $39
- FDA-approved finished medication, not compounded
- Established, full-service platform with strong brand trust
Ro.co cons
- Ongoing medication pricing varies and can be high depending on the plan
- Branded and FDA-approved medications cost significantly more than compounded alternatives
- Less price-competitive than compounded-only platforms for budget-driven patients
Against altRx specifically, the trade you are making: an FDA-approved finished medication costs multiples of a compounded vial.
Picking between them
Choose altRx if:
- the feature you would actually use: the cheapest published tirzepatide rate on this list at $149, with the injection kit included
- the level of clinical contact suits you: responsive care team for ongoing clinician-guided support
- you want to start on their timeline: 100% online medical visits
- delivery works the way you want it to: free, discreet 2-day delivery
Choose Ro.co if:
- delivery works the way you want it to: home delivery
- you want to start on their timeline: online consultation
- the level of clinical contact suits you: established full-service platform with clinician oversight
- what it leads on is worth paying for in your case: the only mainstream platform here offering the FDA-approved Wegovy pill, so no injections at all
The compromises on both sides
On price. Ro.co is the cheaper program at $39/mo against $89/mo. What Ro.co gives up for that is an FDA-approved finished medication costs multiples of a compounded vial; what altRx charges for is the cheapest published tirzepatide rate on this list at $149, with the injection kit included.
On predictability. The pricing structures differ (flat rate at every dose versus promotional first month, then standard rate), and structure, not headline rate, determines the twelve-month bill.
On access. altRx advertises 100% online medical visits and free, discreet 2-day delivery; Ro.co advertises online consultation and home delivery. Coverage differs too — not available in every state against not published — which decides the question before price does if you are in a restricted state.
On medication. altRx covers compounded semaglutide and compounded tirzepatide; Ro.co covers FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables. Only altRx publishes a tirzepatide route, which matters if semaglutide underdelivers.
The medication, not the platform
The efficacy data people cite when comparing these platforms is not platform data. It comes from trials of the underlying medication, and it applies to both.
NIDDK frames medication as one component of obesity treatment rather than a replacement for the rest of it, per NIH, NIDDK.
SURMOUNT-4 found that continuing tirzepatide maintained and extended weight reduction, while withdrawing it led to substantial regain, per JAMA, SURMOUNT-4.
Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.
altRx vs Ro.co: common questions
Does the price go up as my dose increases?
At altRx, no — the cheapest published tirzepatide rate on this list at $149, with the injection kit included. At Ro.co, the published structure is promotional first month, then standard rate. Since GLP-1 doses escalate over the first months, that difference is worth more than most feature comparisons.
Which is cheaper to start, altRx or Ro.co?
Ro.co, at $39 against $89. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
How fast can I start with altRx compared with Ro.co?
altRx advertises 100% online medical visits, with free, discreet 2-day delivery. Ro.co advertises online consultation, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
What happens if I stop taking the medication?
Neither altRx nor Ro.co penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.
Is altRx or Ro.co better for a first GLP-1 prescription?
For a first prescription, weight support over price. altRx offers more contact (responsive care team for ongoing clinician-guided support), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
Are altRx and Ro.co legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. altRx operates on flat rate at every dose with pricing published upfront, Ro.co on promotional first month, then standard rate, partly published. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
The verdict
Ro.co is the cheaper of the two to run at $39/mo, but a full-year total is only computable for one side of this comparison, so treat that as a directional finding rather than a settled one.
altRx's case is the cheapest published tirzepatide rate on this list at $149, with the injection kit included; its cost: the rate is a limited offer and the platform does not operate in every state.
Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.
Keep comparing
- altRx vs Mochi HealthLocked price vs escalating price
- altRx vs NoviBudget vs premium
- TrimRx vs Ro.coBrand-name vs compounded
- Measured vs Ro.coBrand-name vs compounded
- Ro.co vs Start WillowBrand-name vs compounded
- Ro.co vs IVIM HealthBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by altRx or Ro.co, and does not sell treatment. Read our ranking methodology.